Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumors
Interventions: DRUG: Relacorilant with nab-paclitaxel
Sponsor: Corcept Therapeutics